MABVAX THERAPEUTICS HLDGS INC
MBVX
MBVX was delisted on the 10th of July, 2018.
10 hedge funds and large institutions have $119K invested in MABVAX THERAPEUTICS HLDGS INC in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
25% more funds holding
Funds holding: 8 → 10 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less capital invested
Capital invested by funds: $141K → $119K (-$22K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$34.1K |
| 2 |
BW
Bison Wealth
Atlanta,
Georgia
|
+$26.9K |
| 3 |
BJL
Brighton Jones LLC
Seattle,
Washington
|
+$17.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$339 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
Biomark Capital Management
Greenwich,
Connecticut
| $37K | – | – | – |
|
|
2
Bank of America
Charlotte,
North Carolina
| $26K | +$34.1K | +6,332 | New |
|
|
BW
3
Bison Wealth
Atlanta,
Georgia
| $21K | +$26.9K | +5,000 | New |
|
|
DRD
4
Dennis R. Delaney
| $14K | – | – | – |
|
|
BJL
5
Brighton Jones LLC
Seattle,
Washington
| $14K | +$17.9K | +3,333 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $7K | +$339 | +63 | +4% |
|
|
7
Millennium Management
New York
| – | -$46K | -6,791 | Closed |
|
MBVX Hedge Fund Activity: Q2 2017 in Review
10 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in MABVAX THERAPEUTICS HLDGS INC (MBVX) for Q2 2017, worth a combined $119K — down 16% from $141K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MBVX positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $34.1K. The largest seller was Millennium Management, exiting entirely with an estimated $46K sold.
- 10 institutional investors held MABVAX THERAPEUTICS HLDGS INC (MBVX) as of Q2 2017, up from 8 in Q1 2017.
- Funds reported $119K of MABVAX THERAPEUTICS HLDGS INC stock for Q2 2017, down 16% quarter-over-quarter.
- 3 funds opened new MABVAX THERAPEUTICS HLDGS INC positions in Q2 2017 and 1 closed out, a net change of +2 holders.
- The largest MABVAX THERAPEUTICS HLDGS INC buyer in Q2 2017 was Bank of America, an estimated $34.1K added.
- The largest MABVAX THERAPEUTICS HLDGS INC seller in Q2 2017 was Millennium Management, an estimated $46K sold.
Based on aggregated 13F filings for Q2 2017.